Literature DB >> 1932479

Inhibition of gastrin- and histamine-stimulated gastric acid secretion by gastrin and cholecystokinin antagonists in the rat.

B H Hirst1, K J Elliott, H Ryder, M Szelke.   

Abstract

The gastric acid inhibitory activities of a peptide-like gastrin receptor antagonist, Boc-beta Ala-Trp-Leu-Asp-O(CH2)2-Ph-4-F (CH-486), a nonpeptide gastrin/CCK-B antagonist (L-365,260), and a CCK-A antagonist (L-364,718), were investigated in the gastric lumen-perfused anaesthetized rat. A single i.v. injection of CH-486, 100 mumol/kg, reduced acid secretion stimulated by pentagastrin, 15 micrograms kg/h, to unstimulated levels, with no recovery within 50 min. Histamine-, 0.1 mumol kg/min, and carbamylcholine-, 0.1 mg kg/h, stimulated acid secretion were also reduced to unstimulated levels by CH-486, 100 mumol/kg, although with these latter two stimulants the inhibition was transient. L-365,260 and L-364,718, 10 mumol/kg, significantly inhibited both pentagastrin- and histamine-stimulated acid secretion, the latter again transiently. We conclude that the non-selective nature of the gastric acid inhibitory activity of gastrin antagonists might allow novel approaches to control gastric acid secretion in peptic ulcer disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1932479     DOI: 10.1111/j.1365-2036.1991.tb00003.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  5 in total

1.  L-365,260 inhibits in vitro acid secretion by interacting with a PKA pathway.

Authors:  C Oiry; J Pannequin; A Cormier; J C Galleyrand; J Martinez
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat.

Authors:  N J Hayward; M Harding; S A Lloyd; A T McKnight; J Hughes; G N Woodruff
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

3.  Antisecretory and ulcer healing effects of S-0509, a novel CCK-B/gastrin receptor antagonist, in rats.

Authors:  K Amagase; K Ikeda; S Okabe
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

4.  YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs.

Authors:  H Yuki; A Nishida; A Miyake; H Ito; S Akuzawa; Y Takinami; Y Takemoto; K Miyata
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

Review 5.  New molecular targets for treatment of peptic ulcer disease.

Authors:  Frank Lehmann; Pius Hildebrand; Christoph Beglinger
Journal:  Drugs       Date:  2003       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.